New research evaluates clinical trials investigating post-acute COVID-19 syndrome treatment

In a recent article published in Clinical Microbiology and Infection, researchers reviewed all registered trials currently investigating potential treatment options for post-acute coronavirus disease 2019 (COVID-19) syndrome (PACS).

Long COVID and its Management

COVID-19 therapeutics: Challenges and directions for the future

Full article: Short- and potential long-term adverse health outcomes of COVID-19: a rapid review

Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study

Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19

Post COVID‐19 condition diagnosis: A population‐based cohort study of occurrence, associated factors, and healthcare use by severity of acute infection - Hedberg - 2023 - Journal of Internal Medicine - Wiley Online Library

Long covid—mechanisms, risk factors, and management

Peripheral Neuropathy Evaluations of Patients With Prolonged Long COVID

What We Know about Long COVID—and What We Don't, The Brink

Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis - ScienceDirect

Hydroxychloroquine with or without azithromycin for treatment of early SARS-CoV-2 infection among high-risk outpatient adults: A randomized clinical trial - eClinicalMedicine